Inhibitory Effect of Yigan Zhuanyin San on HBsAg and HBeAg in HepG2.2.15 Cell

TANG Ai-cun; CHEN Zhao-ni; LUO Xu-yan; HUANG Ren-bin; WANG Nai-ping

您当前的位置：

首页 >

文章列表页 >

Inhibitory Effect of Yigan Zhuanyin San on HBsAg and HBeAg in HepG2.2.15 Cell

更新时间：2024-01-04

- Inhibitory Effect of Yigan Zhuanyin San on HBsAg and HBeAg in HepG2.2.15 Cell
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 16, Issue 10, Pages: 128-130(2010)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2010
- 稿件说明：
移动端阅览
TANG Ai-cun, CHEN Zhao-ni, LUO Xu-yan, et al. Inhibitory Effect of Yigan Zhuanyin San on HBsAg and HBeAg in HepG2.2.15 Cell[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(10): 128-130.
DOI：

TANG Ai-cun, CHEN Zhao-ni, LUO Xu-yan, et al. Inhibitory Effect of Yigan Zhuanyin San on HBsAg and HBeAg in HepG2.2.15 Cell[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(10): 128-130. DOI：

摘要

目的 :研究乙肝转阴散(YGZYS)对HepG2.2.15细胞乙型肝炎表面抗原(HBsAg)和乙型肝炎E抗原(HBeAg)分泌的影响。方法 :采用四甲基噻唑蓝(MTT)法检测YGZYS对HepG2.2.15细胞的半数毒性浓度(TC50)和最大无毒浓度(TC0);在TC0基础上观察药物5个不同浓度作用于HepG2.2.15细胞

采用酶联免疫吸附法(ELISA)测定培养4 d和8 d的细胞上清液HBsAg和HBeAg的滴度。结果 :TC50 5.386 g ·L-1

TC0 0.736 g ·L-1。提示YGZYS对HepG2.2.15细胞毒性作用较低。在无毒浓度下

YGZYS能有效地抑制HepG2.2.15细胞分泌HBsAg和HBeAg;且治疗指数(TI)均大于2

说明YGZYS为高效低毒的抗HBV药物。结论 :YGZYS可有效地抑制HepG2.2.15细胞HBsAg和HBeAg的分泌

且毒性较低。

Abstract

Objective: To study the effect of traditional Chinese medicine Yigan Zhuanyin San (YGZYS) on HBsAg and HBeAg of HepG2.2.15 cell. Method: The TC50 and TC0 of YGZYS to the HepG2.2.15 cell were determined by MTT assay. At non-toxic range of concentration

five different concentrations of YGZYS were added respectively to HepG2.2.15 cells. At 4d and 8d after treatment with drugs

the supernatant of HepG2.2.15 were collected for determining the levels of HBsAg and HBeAg by ELISA. Result: TC50 5.386 g ·L-1

TC0 0.736 g ·L-1. YGZYS had little cellulotoxicity. YGZYS at the largest non-cellulotoxic concentration could suppress HBsAg and HBeAg expression in HepG2.2.15 cell

and the therapeutic index (TI)>2

YGZYS appeared to be an effective and low toxic anti-HBV drug. Conclusion: YGZYS can suppress HBsAg and HBeAg expression in HepG2.2.15 cell

and is a lower toxic drug.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Hance on HBsAg and HBeAg in the HepG2.2.15 Cells

The Study on the Mechanism of Anti-hepatitis B Virus in vitro by Flavonoids Extract from Milfiol Herb

Related Author

CHEN Xiao-bai

WANG Xiao-ping

WEI Min

GUO Shan-shan1

GAO Ying-jie1

SHI Yu-jing1

SU Dan1

CUI Xiao-lan1

Related Institution

No data

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰